A non-invasive treatment that combines chemotherapy with electrical currents to shrink mesothelioma tumors appear to be working for patients.
A Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy for pleural mesothelioma tumors shows promise for patients.
The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs.
Follow part 1 of Allen’s mesothelioma journey from asbestos exposure to life after treatment and learn what led to Allen's diagnosis.
Not all patients experience the same symptoms of mesothelioma as the stage of illness, overall health, and age play significant roles.
Mesothelioma is difficult to diagnose and sometimes misdiagnosed as other forms of cancer. It takes multiple tests to confirm a diagnosis.
We followed Allen’s mesothelioma survivor journey since the first contact with asbestos. Now, we conclude his journey and his survivor story.
Since 1991, the number of women with mesothelioma and other asbestos illnesses has risen despite partial bans on asbestos.
After a physical examination of certain organs, doctors will order imaging tests like X-rays or CT scans to confirm a mesothelioma diagnosis.
A promising new artificial intelligence (AI) tool could streamline the process of identifying mesothelioma tumors in patients.